Zenas BioPharma (ZBIO) Treasury Shares (2023 - 2026)

Zenas BioPharma (ZBIO) posted quarterly Treasury Shares of $667600.0 for Q1 2026, up 11.33% quarter-over-quarter from $599675.0 in Q4 2025.

Zenas BioPharma (ZBIO) Treasury Shares (2023 - 2026) Analysis & Trends

Zenas BioPharma's Treasury Shares history runs 4 years deep, the most recent figure standing at $667600.0 for Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $667600.0; the TTM figure through Mar 2026 stood at $667600.0 (changed N/A YoY), while the FY2025 annual figure was $599675.0, changed N/A from the prior year.
Treasury Shares for Q1 2026 stood at $667600.0, up from $599675.0 in the prior quarter.
The five-year high for Treasury Shares was $116.3 million in Q2 2024, with the low at $511100.0 in Q2 2025.
The 4-year median for Treasury Shares is $9.1 million (2023), against an average of $37.3 million.
Peak annual rise in Treasury Shares reached 99.56% in 2025, while the deepest fall reached 99.56% in 2025.
Zenas BioPharma's Treasury Shares stood at $17.6 million in 2023, then soared by 561.05% to $116.3 million in 2024, then tumbled by 99.48% to $599675.0 in 2025, then rose by 11.33% to $667600.0 in 2026.
Business Quant data shows ZBIO's Treasury Shares at $667600.0 in Q1 2026, $599675.0 in Q4 2025, and $525350.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Zenas BioPharma	1.87 Bn	748.44 Mn	-	1.26 Mn

Download Data